A systematic in silico mining of the mechanistic implications and therapeutic potentials of estrogen receptor (ER)-a in breast cancer

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Li, Xin ^a   Sun, Rong ^a   Chen, Wanpeng ^a   Lu, Bangmin ^a   Li, Xiaoyu ^a   Wang, Zijie ^a   Bao, Jinku ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MICRORNA; ESTROGEN RECEPTOR ALPHA, HUMAN; HERBACEOUS AGENT; PROTEIN BINDING;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOINFORMATICS; BREAST CANCER; BREAST CARCINOGENESIS; COMPUTER MODEL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; OUTCOME ASSESSMENT; PREDICTION; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; RECEPTOR BINDING ASSAY; VALIDATION PROCESS; ALGORITHM; BREAST NEOPLASMS; COMPUTER SIMULATION; DATA MINING; FEMALE; GENE EXPRESSION REGULATION; GENE ONTOLOGY; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN TERTIARY STRUCTURE; REPRODUCIBILITY;

ALGORITHMS; BREAST NEOPLASMS; COMPUTER SIMULATION; DATA MINING; DRUGS, CHINESE HERBAL; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; HUMANS; MICRORNAS; MOLECULAR DYNAMICS SIMULATION; MOLECULAR SEQUENCE ANNOTATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; REPRODUCIBILITY OF RESULTS;

EID: 84897524099     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091894     Document Type: Article

References (71)

1. Giacinti L, Claudio PP, Lopez M, Giordano A (2006) Epigenetic information and estrogen receptor alpha expression in breast cancer. Oncologist 11: 1-8. doi:10.1634/theoncologist.11-1-1. PubMed: 16401708. (Pubitemid 43152681)
2. Banerjee S, Kambhampati S, Haque I, Banerjee SK (2011) Pomegranate sensitizes Tamoxifen action in ER-a positive breast cancer cells. J Cell Commun Signal 5: 317-324. doi:10.1007/s12079-011-0138-y. PubMed: 21706446.
3. Park WC, Jordan VC (2002) Selective estrogen receptor modulators (SERMS) and their roles in breast cancer prevention. Trends Mol Med 8: 82-88. doi:10.1016/S1471-4914(02)02282-7. PubMed: 11815274. (Pubitemid 34094444)
4. Cuzick J, Sestak I, Bonanni B, Costantino JP, Cummings S, et al. (2013) Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet 381: 1827-1834. doi:10.1016/S0140-6736(13)60140-3. PubMed: 23639488.
5. Schmidt C (2010) Third-generation SERMs may face uphill battle. J Natl Cancer I 102: 1690-1692. doi:10.1093/jnci/djq477. PubMed: 21060064.
6. Howell A, Evans DG (2013) Breast cancer prevention: SERMs come of age. Lancet 381: 1795-1797. doi:10.1016/S0140-6736(13)60443-2. PubMed: 23639489.
7. Nana-Sinkam S, Croce C (2012) Clinical applications for microRNAs in cancer. Clin Pharmacol Ther. doi:10.1038/clpt.2012.192. PubMed: 23212103.
8. Corcoran C, Friel AM, Duffy MJ, Crown J, O'Driscoll L (2011) Intracellular and extracellular microRNAs in breast cancer. Clin Chem 57: 18-32. doi: 10.1373/clinchem.2010.150730. PubMed: 21059829.
9. Tian W, Chen J, He H, Deng Y (2012) MicroRNAs and drug resistance of breast cancer: basic evidence and clinical applications. Clin and Transl Oncol: 15: 335-342. doi:10.1007/s12094-012-0929-5. PubMed: 22914907.
10. Manavathi B, Dey O, Gajulapalli VNR, Bhatia RS, Bugide S, et al. (2013) Derailed estrogen signaling and breast cancer: an authentic couple. Endocr Rev 34: 1-32. doi: 10.1210/er.2011-1057. PubMed: 22947396.
11. Klinge CM (2012) MiRNAs and estrogen action. Trends in Endocrin Met 23: 223-233. doi:10.1016/j.tem.2012.03.002. PubMed: 22503553.
12. Gadaleta E, Lemoine NR, Chelala C (2011) Online resources of cancer data: barriers, benefits and lessons. Brief Bioinform 12: 52-63. doi: 10.1093/bib/bbq010. PubMed: 20348133.
13. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674. doi:10.1016/j.cell.2011.02.013. PubMed: 21376230.
14. Hendriks BS, Hua F, Chabot JR (2008) Analysis of mechanistic pathway models in drug discovery: p38 pathway. Biotechnol Prog 24: 96-109. doi:10.1021/bp070084g. PubMed: 17918858. (Pubitemid 351231254)
15. Prasad TK, Goel R, Kandasamy K, Keerthikumar S, Kumar S, et al. (2009) Human protein reference database-2009 update. Nucleic Acids Res 37: D767-D772. doi:10.1093/nar/gkn892. PubMed: 18988627.
16. Salwinski L, Miller CS, Smith AJ, Pettit FK, Bowie JU, et al. (2004) The database of interacting proteins: 2004 update. Nucleic Acids Res 32: D449-D451. doi:10.1093/nar/gkh086. PubMed: 14681454. (Pubitemid 38081696)
17. Kerrien S, Aranda B, Breuza L, Bridge A, Broackes-Carter F, et al. (2012) The IntAct molecular interaction database in 2012. Nucleic Acids Res 40: D841-D846. doi:10.1093/nar/gkr1088. PubMed: 22121220.
18. Persico M, Ceol A, Gavrila C, Hoffmann R, Florio A, et al. (2005) HomoMINT: an inferred human network based on orthology mapping of protein interactions discovered in model organisms. BMC Bioinformatics 6: S21. doi:10.1186/1471-2105-6-S4-S21. PubMed: 16351748.
19. Chatr-aryamontri A, Breitkreutz BJ, Heinicke S, Boucher L, Winter A, et al. (2013) The BioGRID interaction database: 2013 update. Nucleic Acids Res 41: D816-D823. doi:10.1093/nar/gks1158. PubMed: 23203989.
20. Smoot ME, Ono K, Ruscheinski J, Wang P-L, Ideker T (2011) Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 27: 431-432. doi:10.1093/bioinformatics/btq675. PubMed: 21149340.
21. Butler D (2004) Science searches shift up a gear as Google starts Scholar engine. Nature 432: 423-423. doi:10.1038/432423a. PubMed: 15565113.
22. Hsu SD, Lin FM, Wu WY, Liang C, Huang WC, et al. (2011) miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res 39: D163-D169. doi:10.1093/nar/gkq1107. PubMed: 21071411.
23. Vergoulis T, Vlachos IS, Alexiou P, Georgakilas G, Maragkakis M, et al. (2012) TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support. Nucleic Acids Res 40: D222-D229. doi:10.1093/nar/gkr1161. PubMed: 22135297.
24. Yang JH, Li JH, Shao P, Zhou H, Chen YQ, et al. (2011) starBase: a database for exploring microRNA-mRNA interaction maps from Argonaute CLIP-Seq and Degradome-Seq data. Nucleic Acids Res 39: D202-D209. doi:10.1093/nar/ gkq1056. PubMed: 21037263.
25. Xiao F, Zuo Z, Cai G, Kang S, Gao X, et al. (2009) miRecords: an integrated resource for microRNA-target interactions. Nucleic Acids Res 37: D105-D110. doi:10.1093/nar/gkn851. PubMed: 18996891.
26. Dweep H, Sticht C, Pandey P, Gretz N (2011) miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform 44: 839-847. doi:10.1016/j.jbi.2011.05.002. PubMed: 21605702.
27. Maragkakis M, Alexiou P, Papadopoulos GL, Reczko M, Dalamagas T, et al. (2009) Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 10: 295. doi:10.1186/1471-2105-10-295. PubMed: 19765283.
28. Betel D, Wilson M, Gabow A, Marks DS, Sander C (2008) The microRNA. org resource: targets and expression. Nucleic Acids Res 36: D149-D153. doi:10.1093/nar/gkm995. PubMed: 18158296. (Pubitemid 351149712)
29. Lewis BP, Shih IH, Jones Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798. doi:10.1016/S0092-8674(03)01018-3. PubMed: 14697198. (Pubitemid 38058492)
30. Cirillo F, Nassa G, Tarallo R, Stellato C, De Filippo MR, et al. (2013) Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: identification of novel nuclear cofactors of antiestrogen-ERalpha complexes by interaction proteomics. J Proteome Res 12: 421-431. doi:10.1021/pr300753u. PubMed: 23170835.
31. Yau C, Benz CC (2008) Genes responsive to both oxidant stress and loss of estrogen receptor function identify a poor prognosis group of estrogen receptor positive primary breast cancers. Breast Cancer Res 10: R61. doi:10.1186/bcr2120. PubMed: 18631401.
32. Tusher VG, Tibshirani R, Chu G (2001) Significance analysis of microarrays applied to the ionizing radiation response. P Natl Acad Sci USA 98: 5116-5121. doi:10.1073/pnas.091062498. PubMed: 11309499. (Pubitemid 32397092)
33. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, et al. (2000) Gene Ontology: tool for the unification ofbiology. Nat Genet 25: 25-29. doi:10.1038/75556. PubMed: 10802651. (Pubitemid 30257031)
34. Da Wei Huang BTS, Lempicki RA (2008) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57. doi:10.1038/nprot.2008.211. PubMed: 19131956.
35. Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13. doi:10.1093/nar/gkn923. PubMed: 19033363.
36. Ye J, Fang L, Zheng H, Zhang Y, Chen J, et al. (2006) WEGO: a web tool for plotting GO annotations. Nucleic Acids Res 34: W293-W297. doi:10.1093/nar/gkl031. PubMed: 16845012. (Pubitemid 44529781)
37. Wuchty S, Arjona D, Li A, Kotliarov Y, Walling J, et al. (2011) Prediction of associations between microRNAs and gene expression in glioma biology. PLoS One 6: e14681. doi:10.1371/journal.pone.0014681. PubMed: 21358821.
38. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63. doi:10.1038/nature07228. PubMed: 18668040.
39. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, et al. (1998) The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95: 927-937. doi:10.1016/S0092-8674(00) 81717-1. PubMed: 9875847. (Pubitemid 29019045)
40. Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52: 1757-1768.doi:10.1021/ci3001277. PubMed: 22587354.
41. Huang N, Shoichet BK, Irwin JJ (2006) Benchmarking sets for molecular docking. J Med Chem 49: 6789-6801. doi:10.1021/jm0608356. PubMed: 17154509. (Pubitemid 44749746)
42. Lang PT, Brozell SR, Mukherjee S, Pettersen EF, Meng EC, et al. (2009) DOCK 6: Combining techniques to model RNA-small molecule complexes. RNA 15: 1219-1230. doi:10.1261/rna.1563609. PubMed: 19369428.
43. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, et al. (2004) UCSF Chimera-a visualization system for exploratory research and analysis. J Comput Chem 25: 1605-1612. doi:10.1002/jcc.20084. PubMed: 15264254.
44. Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, et al. (2007) PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 35: W522-W525. doi:10.1093/nar/gkm276. PubMed: 17488841.
45. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, et al. (2011) pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12: 77. doi:10.1186/1471-2105-12-77. PubMed: 21414208.
46. Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, et al. (2005) GROMACS: fast, flexible, and free. J Comput Chem 26: 1701-1718. doi:10.1002/jcc.20291. PubMed: 16211538. (Pubitemid 43076182)
47. Tenette C, Smith JC, Topham CM (1996) Force field development and conformational search strategy in the simulation of biomolecular recognition processes. Biochem Soc Trans 24: 268-274. PubMed: 8674683.
48. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph Model; 14: 33-38. doi:10.1016/0263-7855(96)00018-5. PubMed: 8744570. (Pubitemid 26152973)
49. Bentwich I (2005) Prediction and validation of microRNAs and their targets. FEBS Lett 579: 5904-5910. doi:10.1016/j.febslet.2005.09.040. PubMed: 16214134. (Pubitemid 41484136)
50. Witkos TM, Koscianska E, Krzyzosiak WJ (2011) Practical Aspects of microRNA Target Prediction. Curr Mol Med 11: 93-109. doi:10.2174/ 156652411794859250. PubMed: 21342132.
51. Kar G, Gursoy A, Keskin O (2009) Human cancer protein-protein interaction network: a structural perspective. PLoS Comput Biol 5: e1000601. doi:10.1371/journal.pcbi.1000601. PubMed: 20011507.
52. Ostlund G, Lindskog M, Sonnhammer EL (2010) Network-based identification of novel cancer genes. Mol Cell Proteomics 9: 648-655. doi:10.1074/mcp.M900227- MCP200. PubMed: 19959820.
53. Aragues R, Sander C, Oliva B (2008) Predicting cancer involvement of genes from heterogeneous data. BMC Bioinformatics 9: 172. doi:10.1186/1471-2105- 9-172. PubMed: 18371197.
54. Venkatesan K, Rual JF, Vazquez A, Stelzl U, Lemmens I, et al. (2008) An empirical framework for binary interactome mapping. Nat Methods 6: 83-90. doi:10.1038/nmeth.1280. PubMed: 19060904.
55. Prat A, Baselga J (2008) The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2. Nat Clin Practi Oncol 5: 531-542. doi:10.1038/ncponc1179. PubMed: 18607391.
56. Chen JQ, Delannoy M, Cooke C, Yager JD (2004) Mitochondrial localization of ERa and ERb in human MCF7 cells. Am J Physiol-Endoc M 286: E1011-E1022. doi:10.1152/ajpendo.00508.2003. PubMed: 14736707. (Pubitemid 38668826)
57. McDonnell DP, Wardell SE (2010) The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer. Curr Opin Pharmacol 10: 620-628. doi:10.1016/j.coph.2010.09.007. PubMed: 20926342.
58. Chen JQ, Eshete M, Alworth WL, Yager JD (2004) Binding of MCF-7 cell mitochondrial proteins and recombinant human estrogen receptors a and b to human mitochondrial dna estrogen response elements. J Cell Biochem 93: 358-373. doi:10.1002/jcb.20178. PubMed: 15368362. (Pubitemid 44264212)
59. Chen J, Delannoy M, Odwin S, He P, Trush MA, et al. (2003) Enhanced mitochondrial gene transcript, ATP, bcl-2 protein levels, and altered glutathione distribution in ethinyl estradiol-treated cultured female rat hepatocytes. Toxicol Sci 75: 271-278. doi:10.1093/toxsci/kfg183. PubMed: 12857939. (Pubitemid 37220274)
60. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, et al. (2000) Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem 275: 18447-18453. doi:10.1074/jbc.M910345199. PubMed: 10749889. (Pubitemid 30414803)
61. Simoncini T, Hafezi Moghadam A, Brazil DP, Ley K, Chin WW, et al. (2000) Interaction of oestrogen receptor with the regulatory subunit of phosphatidy-linositol-3-OH kinase. Nature 407: 538-541. doi:10.1038/35035131. PubMed: 11029009.
62. Hah N, Danko CG, Core L, Waterfall JJ, Siepel A, et al. (2011) A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell 145: 622-634. doi:10.1016/j.cell.2011.03.042. PubMed: 21549415.
63. Katchy A, Edvardsson K, Aydogdu E, Williams C (2012) Estradiol-activated estrogen receptor a does not regulate mature microRNAs in T47D breast cancer cells. J Steroid Biochem128: 145-153. doi:10.1016/j.jsbmb.2011.10.008. PubMed: 22079223.
64. Zhang Y, Eades G, Yao Y, Li Q, Zhou Q (2012) Estrogen receptor alpha signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem 287: 41514-41522. doi:10.1074/jbc.M112.404871. PubMed: 23060440.
65. Lanford RE, Hildebrandt-Eriksen ES, Petri A, Persson R, Lindow M, et al. (2010) Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327: 198-201. doi:10.1126/science.1178178. PubMed: 19965718.
66. Tanrikulu Y, Krüger B, Proschak E (2013) The holistic integration of virtual screening in drug discovery. Drug Discov Today. doi:10.1016/j.drudis. 2013. 01.007. PubMed: 23340112.
67. Cao X, Jiang J, Zhang S, Zhu L, Zou J, et al. (2013) Discovery of natural estrogen receptor modulators with structure-based virtual screening. Bioorg Med Chem Lett. doi:10.1016/j.bmcl.2013.03.105. PubMed: 23608764.
68. Yang YD, Carta G, Peters MB, Price T, Boyle NO, et al. (2010) "tieredScreen"-Layered virtual screening tool for the identification of novel estrogen receptor alpha modulators. Mol Inform 29: 421-430. doi:10.1002/minf.20100034.
69. Totrov M, Abagyan R (2008) Flexible ligand docking to multiple receptor conformations: a practical alternative. Curr Opin Struc Biol 18: 178-184. doi:10.1016/j.sbi.2008.01.004. PubMed: 18302984.
70. Pang Y-P, Kozikowski AP (1994) Prediction of the binding sites of huperzine A in acetylcholinesterase by docking studies. J Comput Aid Mol Des 8: 669-681. doi:10.1007/BF00124014. PubMed: 7738603.
71. Cheng LS, Amaro RE, Xu D, Li WW, Arzberger PW, et al. (2008) Ensemble-based virtual screening reveals potential novel antiviral compounds for avian influenza neuraminidase. J Med Chem 51: 3878-3894. doi: 10.1021/jm8001197. PubMed: 18558668. (Pubitemid 351956517)